Stephen Poor
Company: Novartis Institutes for Biomedical Research
Job title: Director
Bio:
UK trained ophthalmologist working in the Ophthalmology research team at the Novartis Institutes for Biomedical Research since 2006. Currently Director of the retina research team with an interest developing novel therapies for macular degeneration, diabetic retinopathy and inherited retinal degenerations.
Seminars:
Panel Discussion: What Does the Future Hold for Complement Therapies? 3:00 pm
This is your opportunity to chat directly with the speakers and voice your own thoughts and research on the future of complement therapiesRead more
day: Day Two
Analysis of Complement in of Donor/Post-Mortem Eyes With & Without Age-Related Macular Degeneration (AMD), Implications for Future Intermediate AMD or Geographic Atrophy (GA) Clinical Trials 12:00 pm
Download the Full Event Guide to find out moreRead more
day: Day Two